<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1331179</PMID><DateCompleted><Year>1992</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9738</ISSN><JournalIssue CitedMedium="Print"><Volume>90</Volume><Issue>5</Issue><PubDate><Year>1992</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Verapamil ameliorates the clinical and pathological course of murine myocarditis.</ArticleTitle><Pagination><StartPage>2022</StartPage><EndPage>2030</EndPage><MedlinePgn>2022-30</MedlinePgn></Pagination><Abstract><AbstractText>The effects of the calcium channel blocking agent, verapamil, were studied in a murine model of viral myocarditis. Three groups of 8-wk-old DBA/2 mice (n = 25 each) were inoculated with 10 plaque-forming units of encephalomyocarditis virus and randomized to three treatment regimens. Group 1 mice received verapamil intraperitoneally (5 mg/kg per d) for 7 d before infection, followed by verapamil orally (mean dose of 3.5 mg/mouse per d) in drinking water during infection. Group 2 mice received only verapamil orally starting on day 4 after infection, coincident with peak viremia. Group 3 (infected control) received no verapamil in regular drinking water after viral inoculation. Additional control animals were studied in group 4 (n = 21), consisting of uninfected control animals receiving intraperitoneal and oral verapamil at doses identical to group 1, and in group 5 (n = 21), consisting of uninfected and untreated controls. Animals were randomly killed from each group (n = 7) at 7, 14, and 28 d after infection. Routine histology was performed blindly on an apical slice of each heart and semi-quantitatively graded for inflammation, necrosis, calcification, and fibrosis on a scale of 0-4. Digital planimetry was performed to measure the absolute and relative areas of inflammation and necrosis. The pretreated animals in group 1 showed marked reduction in inflammation and necrosis (score of 3.7 +/- 1.4 vs. 8.7 +/- 2.0 in group 3 on day 14, P &lt; 0.05) and were indistinguishable from the posttreated group 2 mice (score of 4.0 +/- 1.5 vs. 8.7 +/- 2.0 in group 3 on day 14, P &lt; 0.05). All the uninfected control animals (groups 4 and 5) showed no myocardial lesions whether treated with verapamil or not. Quantitative planimetry confirmed decreased inflammation and necrosis (2.0 +/- 3.3% in group 1 and 3.5 +/- 3.1% in group 2 vs. 21.9 +/- 22.6% in group 3 on day 14). Untreated infected hearts injected with liquid silicone rubber exhibited extensive areas of focal microvascular constriction and microaneurysm formation; verapamil treatment in either group 1 or 2 completely abolished these abnormalities, resembling uninfected controls in groups 4 or 5. We conclude that verapamil, whether given before infection or after peak viremia in an encephalomyocarditis model of murine myocarditis, significantly reduces the microvascular changes and myocardial necrosis, fibrosis, and calcification leading to cardiomyopathy. This suggests the potentially important role of calcium and microvascular spasm in the pathogenesis of viral myocarditis leading to dilated cardiomyopathy, and may have future therapeutic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Toronto Hospital, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Butany</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sole</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>CJ0O37KU29</RegistryNumber><NameOfSubstance UI="D014700">Verapamil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="N">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004686" MajorTopicYN="Y">Encephalomyocarditis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008811" MajorTopicYN="N">Mice, Inbred DBA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014700" MajorTopicYN="N">Verapamil</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1992</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1331179</ArticleId><ArticleId IdType="pmc">PMC443266</ArticleId><ArticleId IdType="doi">10.1172/JCI116082</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am Heart J. 1989 Jul;118(1):173-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2545091</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1982 Mar;50(3):405-12</Citation><ArticleIdList><ArticleId IdType="pubmed">6460569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1987 Nov;10(5):1128-38</Citation><ArticleIdList><ArticleId IdType="pubmed">2822790</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1987 Nov;61(5):715-25</Citation><ArticleIdList><ArticleId IdType="pubmed">2889539</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1985 Nov;6(5):1078-82</Citation><ArticleIdList><ArticleId IdType="pubmed">2995470</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1985 Dec;56(4):701-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3000928</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1986 Apr;7(4):868-72</Citation><ArticleIdList><ArticleId IdType="pubmed">3007597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 1986;488:44-64</Citation><ArticleIdList><ArticleId IdType="pubmed">3034122</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Probl Cardiol. 1987 Oct;12(10):569-647</Citation><ArticleIdList><ArticleId IdType="pubmed">3322687</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1988 Sep;12(3):727-36</Citation><ArticleIdList><ArticleId IdType="pubmed">3403832</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1985 Mar;134(3):1640-3</Citation><ArticleIdList><ArticleId IdType="pubmed">3918108</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Trop Med Hyg. 1985 Mar;34(2):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">3985268</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1985 Oct 1;95(1):46-53</Citation><ArticleIdList><ArticleId IdType="pubmed">4028171</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1982 Aug;66(2):342-54</Citation><ArticleIdList><ArticleId IdType="pubmed">7094244</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Exp Pathol. 1978 Feb;59(1):13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">638027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1990 Jun;15(7):1688-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2161026</ArticleId></ArticleIdList></Reference><Reference><Citation>J Lab Clin Med. 1986 Apr;107(4):393-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2420912</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1989 Feb;64(2):179-92</Citation><ArticleIdList><ArticleId IdType="pubmed">2536302</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1989 Sep;14(3):782-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2671096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1986 May 17;1(8490):1120-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2871380</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1985 Jun;71(6):1247-54</Citation><ArticleIdList><ArticleId IdType="pubmed">2986878</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1986 Feb;122(2):284-91</Citation><ArticleIdList><ArticleId IdType="pubmed">3004227</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1987 Apr 15;138(8):2488-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3031159</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1986 Aug;16(8):907-12</Citation><ArticleIdList><ArticleId IdType="pubmed">3091377</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1986 May;73(5):1058-64</Citation><ArticleIdList><ArticleId IdType="pubmed">3698228</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1986 Feb;73(2):353-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3943167</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1985 Oct;6(4):797-801</Citation><ArticleIdList><ArticleId IdType="pubmed">4031294</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 1984 Nov;108(5):1318-26</Citation><ArticleIdList><ArticleId IdType="pubmed">6093491</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1980 Mar;98(3):681-94</Citation><ArticleIdList><ArticleId IdType="pubmed">6244737</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1984 Jul;116(1):9-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6742110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab Invest. 1992 Jan;66(1):24-31</Citation><ArticleIdList><ArticleId IdType="pubmed">1309927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab Invest. 1991 Jan;64(1):55-64</Citation><ArticleIdList><ArticleId IdType="pubmed">1990209</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1990 Jul;82(1):8-16</Citation><ArticleIdList><ArticleId IdType="pubmed">2163780</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1990 Sep;82(3):982-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2168299</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Jan;168(1):187-90</Citation><ArticleIdList><ArticleId IdType="pubmed">2535903</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 1980 May;45(5):1037-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7369134</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1984 Dec;133(6):2904-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6092460</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1982 Aug;66(2):355-60</Citation><ArticleIdList><ArticleId IdType="pubmed">6212162</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1984 Jul;116(1):21-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6331168</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1987 Sep;84(17):6272-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2819870</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>